Need help now? Support now: crisis lines by country.
Pain words · Mathematical Institute for Research of Pain
Minimal clinically important difference
Also called MCID, minimal important difference or MID
The minimal clinically important difference is the smallest change in a score that patients, on average, experience as meaningful, estimated for a particular scale and group of people.
In plain words
A pain score falls by one point after a treatment. Is that a change people would care about? The minimal clinically important difference tries to answer this by linking changes in a score to what people say about their own change. It is a yardstick for reading trial results, not a pass mark for anyone’s pain.
What researchers mean
Jaeschke, Singer and Guyatt (1989) introduced the idea and estimated it by comparing changes in questionnaire scores with patients’ own global ratings of change: the smallest difference in score that patients perceive as beneficial and that would lead to a change in care, absent troublesome side effects or excessive cost. For 0 to 10 pain ratings in chronic pain, Farrar and colleagues (2001) pooled ten placebo-controlled trials with 2,724 participants. On average, a fall of about 2 points, or about 30%, matched patients rating themselves “much improved” or “very much improved”, and the percentage change was more consistent across starting levels than the change in points. That anchor is larger than a minimal change. The IMMPACT group recommends judging clinical importance with two or more methods (Dworkin and colleagues, 2008).
These are averages over groups of people with particular conditions. They are not a threshold for whether a change matters to one person, and a smaller change can matter a great deal.
The maths
The percentage change from the starting rating, the measure Farrar and colleagues found more consistent across starting levels:
- percentage change
- starting rating
- later rating
Defined only when the starting rating is above 0; the same fall in points is a larger percentage from a lower start.
These pages explain words, reasoning and evidence. Nothing here is medical advice or a forecast about any person.
Sources
- Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415. doi:10.1016/0197-2456(89)90005-6
- Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–158. doi:10.1016/S0304-3959(01)00349-9
- Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121. doi:10.1016/j.jpain.2007.09.005
Related words
Questions about this
Inside the Institute
Pain math explains what the Institute does, and Questions about pain answers some questions people in pain ask, in the same layers. The rooms, the Lab and the full Pain Bias Codex open with an invite code.
No code yet? Ask for an invite. A person reads every request and writes back by hand with an invite code, so it may take a few days.
Need help now? Support now: crisis lines by country.
Except where a page says otherwise, the Institute’s own text and figures are shared under CC BY-NC 4.0. Pictures and quotations from others keep their own credits and licences.